NovMetaPharma Co (XKRX:229500) Total Payout Ratio : 0.64 (As of May. 07, 2024)

View and export this data going back to 2015. Start your Free Trial

What is NovMetaPharma Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

NovMetaPharma Co's current Total Payout Ratio is 0.64.

NovMetaPharma Co Total Payout Ratio Historical Data

The historical data trend for NovMetaPharma Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovMetaPharma Co Total Payout Ratio Chart

NovMetaPharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Payout Ratio

Get a 7-Day Free Trial

0.91

0.64

NovMetaPharma Co Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Total Payout Ratio	Get a 7-Day Free Trial				0.91	-	-	-	0.64

Competitive Comparison of NovMetaPharma Co's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, NovMetaPharma Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovMetaPharma Co's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NovMetaPharma Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where NovMetaPharma Co's Total Payout Ratio falls into.

NovMetaPharma Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

NovMetaPharma Co's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	7999.943	+	0)	/	-12555.185
	=	0.64

NovMetaPharma Co's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	7999.943	+	0)	/	-12555.185
	=	0.64

NovMetaPharma Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

NovMetaPharma Co (XKRX:229500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NovMetaPharma Co Ltd (XKRX:229500) » Definitions » Total Payout Ratio

Traded in Other Exchanges

N/A

Address

727 13, Gangnam-gu, Seoul eonju layer, Seoul, KOR

Website

http://www.novmeta.com

NovMetaPharma Co Ltd researches and develops new medicines and health supplements for metabolic diseases. The company is developing a therapeutic agent that is in Phase 2a clinical trial for Type 2 diabetes and obesity. It also develops therapeutic agents for Alzheimer's disease, immune system diseases, osteoporosis, and non-alcoholic fatty liver diseases.

NovMetaPharma Co (XKRX:229500) Headlines

No Headlines